Activest Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Activest Wealth Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4K	Hold	4,001	–	–	﹤0.01%	577
2026 Q1	$12.3K	Hold	4,001	–	–	﹤0.01%	638
2025 Q4	$14.2K	Hold	4,001	–	–	﹤0.01%	584
2025 Q3	$35.6K	Hold	4,001	–	–	0.01%	298
2025 Q2	$36.9K	Hold	4,001	–	–	0.01%	244
2025 Q1	$34.3K	Hold	4,001	–	–	0.01%	224
2024 Q4	$43K	Hold	4,001	–	–	0.01%	181
2024 Q3	$22.7K	Hold	4,001	–	–	0.01%	242
2024 Q2	$16.9K	Buy	+4,001	New	+$16.2K	0.01%	250

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Activest Wealth Management's AVXL Position: Q2 2026 in Review

Activest Wealth Management held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 4,001 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

Activest Wealth Management first reported a position in AVXL in Q2 2024 and has held it in 9 quarters since. The position peaked at $43K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Activest Wealth Management held 4,001 shares of Anavex Life Sciences worth $10.4K as of Q2 2026.
Activest Wealth Management left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #577 holding.
Activest Wealth Management first reported a position in Anavex Life Sciences in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Anavex Life Sciences position peaked at $43K in Q4 2024.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.